Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
Top Cited Papers
- 1 April 2012
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 149 (2), 307-321
- https://doi.org/10.1016/j.cell.2012.02.053
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- iProphet: Multi-level Integrative Analysis of Shotgun Proteomic Data Improves Peptide and Protein Identification Rates and Error EstimatesMolecular & Cellular Proteomics, 2011
- Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinaseProceedings of the National Academy of Sciences, 2011
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and ActivityCancer Cell, 2011
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3KCancer Cell, 2010
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivationNature, 2010
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- The (un)targeted cancer kinomeNature Chemical Biology, 2010
- Large-scale Proteomics Analysis of the Human KinomeMolecular & Cellular Proteomics, 2009
- Mapping and quantifying mammalian transcriptomes by RNA-SeqNature Methods, 2008
- Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsNature Biotechnology, 2007